Location History:
- Slough, GB (2012)
- Berkshire, GB (2014 - 2016)
Company Filing History:
2 out of 216 
2 out of 138 
1 out of 179 
Years Active: 2012-2016
Title: The Innovative Work of Inventor Anthony Shock
Introduction
Anthony Shock, an accomplished inventor based in Berkshire, GB, has made significant contributions to the field of biotechnology. With a total of three patents to his name, his work primarily focuses on binding proteins, particularly those that interact with the CD154 (CD40L) protein. His inventive journey reflects a commitment to advancing medical science and improving therapeutic strategies for immune-related diseases.
Latest Patents
Among Anthony Shock's noteworthy patents is an invention that provides binding proteins, including antibodies, antibody derivatives, and antibody fragments, which specifically bind to CD154. This patented technology involves chimeric, humanized, or fully human antibodies that target a specific epitope, creating a framework for innovative diagnostic and therapeutic methods. The CD154 binding proteins have shown potential in eliciting reduced effector functions relative to other anti-CD154 antibodies, making them critical in the treatment and prevention of diseases that involve undesirable immune responses mediated by CD154-CD40 interactions.
Career Highlights
Throughout his career, Anthony has worked with prominent organizations, including Biogen Idec MA Inc. and UCB Biopharma Sprl. His experiences at these leading biotechnology companies have enriched his understanding of the industry and contributed to his inventive output. His deep expertise in biotechnology is underscored by the impactful inventions he has developed.
Collaborations
Anthony's journey in innovation has also seen him collaborate with esteemed colleagues such as Linda C. Burkly and Janine L. Ferrant-Orgettas. These partnerships have broadened the horizons of his research and provided a dynamic environment for the exchange of ideas and advancements in the field of immunology.
Conclusion
In summary, Anthony Shock stands out as an innovative inventor dedicated to advancing the understanding and treatment of immune-related diseases. His patents reflect significant advancements in binding protein technology and demonstrate the vital role of collaboration and experience in fostering innovation. As the field of biotechnology continues to evolve, Anthony’s contributions will undoubtedly have lasting effects on therapeutic methodologies.